Thc conditions for refolding reduced and denatured human serum albumin (HSA) were investigated with a view to maximising the yield of native monomeric albumin. Refolding by dialysis was found to be preferable to dilution as a means of chaotrope (urea) and reductant (2-mercaptoethanol) removal. Dialysis of denatured HSA solutions containing 4-8 M urea and 14 mM 2-mercaptoethanol at pH 10.0 was found to be optimal for HSA refolding. The yield of monomeric HSA was maximal (94%) for dialysis in the presence of EDTA (1 mM) and sodium palmitate (20 pM). Using this protocol it was possible to refold HSA at concentrations in excess of 5 mg . ml-' whilst maintaining a high recovery of native monomer. These results represent a considerable improvement on established methods of HSA refolding.A common approach to solving the enigma of protein folding has been to observe the refolding of reversibly denatured proteins in vitro. The intrinsic ability of large, disulphide-bonded proteins to refold correctly from a reduced and denatured state was demonstrated by Anfinsen and coworkers from their studies on ribonuclease [l, 21. Since then a number of proteins have been refolded to their original native conformations [3 -61. Traditional protocols for refolding reduced and denatured proteins involve the removal of the chaotrope and thiol reductant by dilution or dialysis in an oxidative environment. To combat the frequently encountered problems of protein aggregation and incorrectly formed disulphide bonds, the denatured protein is commonly diluted to micromolar concentration and refolded in the presence of disulphide/thiol containing buffers [4, 71 or disulphide exchange enzymes [8, 91. Interest in protein refolding has intensified in recent years with the advent of recombinant DNA technology. Heterologous proteins expressed in microorganisms are frcquently insoluble within the cell and their recovery in a soluble form often necessitates renaturation of a chaotrope-reductant extract. Large-scale protein refolding places high demands on the renaturation protocol, since long refolding times, large volumes of dilute protein solution and poor recoveries of native material are unacceptable in a production process. Thus a requirement exists for highly efficient protein refolding regimes.Serum albumin provides an interesting model for protein refolding studies since, in order to regenerate the native protein 17, disulphide bonds must be correctly reformed [3]. Human serum albumin (HSA) is also a valued therapeutic product which has been expressed as an intracellular recombinant protein in a number of organisms [lo-121. In the majority of these examples the recombinant HSA forms C,'itrrespontf~~nce to A. V. Quirk,